Viewing Study NCT01294735


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2025-12-25 @ 7:49 PM
Study NCT ID: NCT01294735
Status: COMPLETED
Last Update Posted: 2012-08-15
First Post: 2011-02-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module